Return On Equity of Arch Therapeutics, Inc. from 31 Dec 2012 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Arch Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2012 to 30 Jun 2024.
  • Arch Therapeutics, Inc. Return On Equity for the quarter ending 30 Jun 2024 was 121%, a 16% increase year-over-year.
  • Arch Therapeutics, Inc. annual Return On Equity for 2023 was 100%, a 35% decline from 2022.
  • Arch Therapeutics, Inc. annual Return On Equity for 2022 was 154%, a 94% decline from 2021.
  • Arch Therapeutics, Inc. annual Return On Equity for 2021 was 2692%, a 253% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Arch Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 121% +16% +16% 01 Apr 2024 30 Jun 2024
Q1 2024 94% -16% -15% 01 Jan 2024 31 Mar 2024
Q4 2023 100% -29% -22% 01 Oct 2023 31 Dec 2023
Q3 2023 100% -54% -35% 01 Jul 2023 30 Sep 2023
Q2 2023 105% -91% -46% 01 Apr 2023 30 Jun 2023
Q1 2023 110% -272% -71% 01 Jan 2023 31 Mar 2023
Q4 2022 129% -3266% -96% 01 Oct 2022 31 Dec 2022
Q3 2022 154% -2538% -94% 01 Jul 2022 30 Sep 2022
Q2 2022 196% -1479% -88% 01 Apr 2022 30 Jun 2022
Q1 2022 383% -514% -57% 01 Jan 2022 31 Mar 2022
Q4 2021 3394% +3055% +899% 01 Oct 2021 31 Dec 2021
Q3 2021 2692% +1929% +253% 01 Jul 2021 30 Sep 2021
Q2 2021 1675% +741% +79% 01 Apr 2021 30 Jun 2021
Q1 2021 896% -220% -20% 01 Jan 2021 31 Mar 2021
Q4 2020 340% -787% -70% 01 Oct 2020 31 Dec 2020
Q3 2020 763% -224% -23% 01 Jul 2020 30 Sep 2020
Q2 2020 934% +7311% 01 Apr 2020 30 Jun 2020
Q1 2020 1117% +2002% 01 Jan 2020 31 Mar 2020
Q4 2019 1127% +1748% 01 Oct 2019 31 Dec 2019
Q3 2019 987% +1205% 01 Jul 2019 30 Sep 2019
Q2 2019 -6378% -6190% -3291% 01 Apr 2019 30 Jun 2019
Q1 2019 -886% -733% -482% 01 Jan 2019 31 Mar 2019
Q4 2018 -622% -489% -368% 01 Oct 2018 31 Dec 2018
Q3 2018 -219% -157% -256% 01 Jul 2018 30 Sep 2018
Q2 2018 -188% +14% +6.7% 01 Apr 2018 30 Jun 2018
Q1 2018 -152% +41% +21% 01 Jan 2018 31 Mar 2018
Q4 2017 -133% +124% +48% 01 Oct 2017 31 Dec 2017
Q3 2017 -61% +233% +79% 29 Sep 2017 02 Oct 2017
Q2 2017 -202% +161% +44% 01 Apr 2017 30 Jun 2017
Q1 2017 -193% +495% +72% 01 Jan 2017 31 Mar 2017
Q4 2016 -257% -817% -146% 01 Oct 2016 31 Dec 2016
Q3 2016 -295% -418% -338% 01 Jul 2016 30 Sep 2016
Q2 2016 -362% -375% -2847% 01 Apr 2016 30 Jun 2016
Q1 2016 -689% -680% -7519% 01 Jan 2016 31 Mar 2016
Q4 2015 560% +464% +478% 01 Oct 2015 31 Dec 2015
Q3 2015 124% -13% -9.8% 01 Jul 2015 30 Sep 2015
Q2 2015 13% -220% -94% 01 Apr 2015 30 Jun 2015
Q1 2015 -9% -498% -102% 01 Jan 2015 31 Mar 2015
Q4 2014 97% -3808% -98% 01 Oct 2014 31 Dec 2014
Q3 2014 137% +3285% 01 Jul 2014 30 Sep 2014
Q2 2014 233% +45% +24% 01 Apr 2014 30 Jun 2014
Q1 2014 488% +352% +257% 01 Jan 2014 31 Mar 2014
Q4 2013 3905% +3791% +3338% 01 Oct 2013 31 Dec 2013
Q3 2013 -3148% 01 Jul 2013 30 Sep 2013
Q2 2013 188% 01 Apr 2013 30 Jun 2013
Q1 2013 137% 01 Jan 2013 31 Mar 2013
Q4 2012 114% 01 Oct 2012 31 Dec 2012

Arch Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 100% -54% -35% 01 Oct 2022 30 Sep 2023
2022 154% -2538% -94% 01 Oct 2021 30 Sep 2022
2021 2692% +1929% +253% 01 Oct 2020 30 Sep 2021
2020 763% -224% -23% 01 Oct 2019 30 Sep 2020
2019 987% +1205% 01 Oct 2018 30 Sep 2019
2018 -219% +27% +11% 01 Oct 2017 30 Sep 2018
2017 -246% +49% +17% 01 Oct 2016 30 Sep 2017
2016 -295% -418% -338% 01 Oct 2015 30 Sep 2016
2015 124% -13% -9.8% 01 Oct 2014 30 Sep 2015
2014 137% +3285% 01 Oct 2013 30 Sep 2014
2013 -3148% 01 Oct 2012 30 Sep 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.